Guangdong Jiaying Pharmaceutical Co Ltd (002198) — Cash Flow Reinvestment Rate
Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Cash Flow Reinvestment Rate of 0.13x as of December 2024, reinvesting CN¥5.65 Million (capex CN¥4.57 Million plus investments CN¥1.08 Million) from operating cash flow of CN¥43.63 Million. Check Guangdong Jiaying Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangdong Jiaying Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2004–2025)
Historical reinvestment intensity for Guangdong Jiaying Pharmaceutical Co Ltd across 22 annual periods. Explore Guangdong Jiaying Pharmaceutical Co Ltd (002198) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Year-by-year capital reinvestment analysis for Guangdong Jiaying Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Guangdong Jiaying Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 15.57x | CN¥140.15 Million | CN¥9.00 Million | CN¥109.92 Million | ▲ +2067.8% |
| 2024 | 0.72x | CN¥43.70 Million | CN¥60.85 Million | CN¥38.70 Million | ▲ +738.6% |
| 2023 | 0.09x | CN¥8.43 Million | CN¥98.45 Million | CN¥5.06 Million | ▼ -95.7% |
| 2022 | 1.98x | CN¥53.77 Million | CN¥27.15 Million | CN¥2.74 Million | ▲ +194.4% |
| 2021 | 0.67x | CN¥34.84 Million | CN¥51.80 Million | CN¥2.34 Million | ▲ +115.9% |
| 2020 | 0.31x | CN¥30.18 Million | CN¥96.87 Million | CN¥11.68 Million | ▼ -96.2% |
| 2019 | 8.11x | CN¥105.13 Million | CN¥12.96 Million | CN¥18.82 Million | ▲ +428.7% |
| 2018 | 1.53x | CN¥95.26 Million | CN¥62.10 Million | CN¥8.95 Million | ▲ +107.1% |
| 2017 | 0.74x | CN¥22.69 Million | CN¥30.63 Million | CN¥18.44 Million | ▲ +171.7% |
| 2016 | 0.27x | CN¥14.48 Million | CN¥53.13 Million | CN¥11.98 Million | ▼ -72.8% |
| 2015 | 1.00x | CN¥42.42 Million | CN¥42.31 Million | CN¥33.42 Million | ▲ +4.9% |
| 2014 | 0.96x | CN¥98.74 Million | CN¥103.36 Million | CN¥98.74 Million | ▲ +113.3% |
| 2013 | 0.45x | CN¥8.72 Million | CN¥19.46 Million | CN¥8.72 Million | ▼ -64.1% |
| 2012 | 1.25x | CN¥6.58 Million | CN¥5.27 Million | CN¥6.58 Million | ▼ -90.9% |
| 2011 | 13.78x | CN¥10.77 Million | CN¥781.89K | CN¥10.77 Million | ▲ +661.8% |
| 2010 | 1.81x | CN¥35.62 Million | CN¥19.70 Million | CN¥35.62 Million | ▼ -34.2% |
| 2009 | 2.75x | CN¥76.95 Million | CN¥27.98 Million | CN¥76.95 Million | ▲ +1.4% |
| 2008 | 2.71x | CN¥29.05 Million | CN¥10.71 Million | CN¥29.05 Million | ▲ +473.6% |
| 2007 | 0.47x | CN¥8.68 Million | CN¥18.35 Million | CN¥8.68 Million | ▼ -3.7% |
| 2006 | 0.49x | CN¥12.95 Million | CN¥26.37 Million | CN¥12.95 Million | ▲ +42.1% |
| 2005 | 0.35x | CN¥6.09 Million | CN¥17.63 Million | CN¥6.09 Million | ▼ -83.2% |
| 2004 | 2.05x | CN¥18.04 Million | CN¥8.78 Million | CN¥18.04 Million | — |